INS and Hyperglycemia: Given that hyperglycemia worsens systemic inflammation, organ function and mortality in sepsis (17–29), dopaminergic agonists such as fenoldopam may provide therapeutic advantages for both metabolic and immune alterations in sepsis and other critical conditions that induces insulin resistant hyperglycemia.